AFWM
IONS icon

Abich Financial Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Abich Financial Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$112K Buy
+1,708
New +$83.4K 0.04% 214
2024
Q3 		$5.25K Buy
131
+86
+191% +$4K 0.01% 255
2024
Q2 		$2.15K Buy
45
+41
+1,025% +$1.68K ﹤0.01% 478
2024
Q1 		$173 Buy
+4
New +$191 ﹤0.01% 492

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Abich Financial Wealth Management's IONS Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2025: 1,708 shares worth $112K. The stake represents 0.04% of the portfolio and ranks #214 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in IONS as recently as Q3 2024.

Abich Financial Wealth Management first reported a position in IONS in Q1 2024 and has held it in 4 quarters since. 436 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

  • Abich Financial Wealth Management held 1,708 shares of Ionis Pharmaceuticals worth $112K as of Q3 2025.
  • Ionis Pharmaceuticals was a new Abich Financial Wealth Management position in Q3 2025.
  • Ionis Pharmaceuticals made up 0.04% of Abich Financial Wealth Management's portfolio in Q3 2025, its #214 holding.
  • Abich Financial Wealth Management first reported a position in Ionis Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • 436 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.